|
Online Case Report Submission for Doctors
Please read the following case submission criteria and program rules prior to submitting a case report.
Case Submission Criteria - Lesion criteria for Case Report Program
Photo Submission Criteria:
*Three (3) digital images (minimum res. 1280 X 1084 pixels) or three (3) high quality photo prints must be submitted and must capture all of the following:
- The suspicious area under incandescent light.
- The same suspicious area/lesion under ViziLite.
- The same suspicious area/lesion stained with TBlue.
- Each submitted image or print must have a common anatomical landmark (i.e., teeth).
Acceptable lesion categorization:
- Exophytic lump or mass, not well-defined
- Homogeneous leukoplakia, erythroplakia or erythroleukoplakia
- Ulceration with irregular, raised or indistinct margins
- Granular or verrucous mucosal change
- Clinical impression of a positive Visual Examination (VE) and/or ViziLite Examination (V+); i.e., defined as positive VE based on the criteria of #'s 1-4 for suspicious lesions above, and/or V+.
Not acceptable lesion categorization:
- Flat ulceration with smooth and distinct margins present > 2 weeks
- Well-defined exophytic submucosal mass with normal-appearing surface
- Discoloration due to dental materials (e.g., amalgam tattoo)
- Ethnic pigmentation from melanin deposition
- Common benign conditions (e.g., linea alba)
ViziLite Plus Case Report Program Rules
- This program is intended only for purchasers of ViziLite and the ViziLite Plus oral lesion identification and marking system.
- By submitting a case under the ViziLite Plus Case Report Program, the submitting practice agrees to be bound by the rules of the program.
- The decision to accept or reject any submitted case is the sole decision of Zila Pharmaceuticals, Inc.
- Zila Pharmaceuticals, Inc. may post accepted case report summaries on its professional and patient web sites.
- Upon acceptance of a submitted case report, Zila Pharmaceuticals, Inc. will remit a payment of $500.00 to the submitting dentist per standard Zila Pharmaceuticals, Inc. accounts payable processes to the address of record at the time of payment.
- Zila Pharmaceuticals, Inc., as the sponsor of this program, reserves the right to modify or discontinue the program at any time.
|